Mucolytic Syrup in pharma franchise in Tripura

Mucolytic Syrup in PCD pharma franchise in Raipur

Mucolytic Syrup in top pharma company in Mumbai

Mucolytic Syrup in pcd pharma supplier in Delhi

Mucolytic Syrup in phama franchise company in India
Mucolytic Syrup in phama distributor in Bangalore

Home/Products /ambroxol-15mg-5ml-guaifenesin-50mg-5ml-levocetirizine-menthol-1mg-5ml-syrup

Cufsniff AL Syrup

Composition : Ambroxol (15mg/5ml) + Guaifenesin (50mg/5ml) + Levocetirizine (2.5mg/5ml) + Menthol (1mg/5ml)

Dosage Form : Syrup

Packaging Type : with measuring Cap

Packaging : 100 Ml

Price : ₹116/-

Cufsniff AL Syrup is a well-balanced combination of Ambroxol (15 mg/5 ml), Guaifenesin (50 mg/5 ml), Levocetirizine (2.5 mg/5 ml), and Menthol (1 mg/5 ml). This syrup is specially formulated to provide effective relief from respiratory conditions associated with cough, mucus buildup, and allergic symptoms. It is an ideal choice for individuals experiencing difficulty breathing due to excessive mucus and associated allergic reactions.

Ambroxol acts as a mucolytic, helping to break down and thin mucus, facilitating its expulsion and relieving congestion. Guaifenesin is an expectorant that helps loosen phlegm and makes coughs more productive. Levocetirizine, an antihistamine, alleviates allergy symptoms such as runny nose, sneezing, and itchy throat, while Menthol provides a cooling sensation and soothes irritated airways. This combination ensures comprehensive management of cough, mucus, and associated allergic symptoms.

Cufsniff AL Syrup is suitable for managing acute and chronic respiratory conditions such as bronchitis, allergic rhinitis, and postnasal drip syndrome. Its palatable taste ensures high patient compliance, especially in children and individuals who prefer liquid formulations.

Read More

About the Product

Cufsniff AL Syrup is a well-balanced combination of Ambroxol (15 mg/5 ml), Guaifenesin (50 mg/5 ml), Levocetirizine (2.5 mg/5 ml), and Menthol (1 mg/5 ml). This syrup is specially formulated to provide effective relief from respiratory conditions associated with cough, mucus buildup, and allergic symptoms. It is an ideal choice for individuals experiencing difficulty breathing due to excessive mucus and associated allergic reactions.

Ambroxol acts as a mucolytic, helping to break down and thin mucus, facilitating its expulsion and relieving congestion. Guaifenesin is an expectorant that helps loosen phlegm and makes coughs more productive. Levocetirizine, an antihistamine, alleviates allergy symptoms such as runny nose, sneezing, and itchy throat, while Menthol provides a cooling sensation and soothes irritated airways. This combination ensures comprehensive management of cough, mucus, and associated allergic symptoms.

Cufsniff AL Syrup is suitable for managing acute and chronic respiratory conditions such as bronchitis, allergic rhinitis, and postnasal drip syndrome. Its palatable taste ensures high patient compliance, especially in children and individuals who prefer liquid formulations.

Common side effects include mild drowsiness, dry mouth, or stomach upset. Discontinue use and consult a doctor if adverse reactions persist.

Relieves cough, clears mucus, and alleviates allergic respiratory symptoms such as sneezing and runny nose.

Use under medical supervision, especially in pregnant or breastfeeding individuals. Not recommended for use in children under two years without a doctor's advice.

Store in a cool, dry place below 30°C, away from direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation